Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
Inserm · Université Paris Sciences et Lettres · +2 more institutions
Abstract
Although heterogeneity of FAP+ Cancer-Associated Fibroblasts (CAF) has been described in breast cancer, their plasticity and spatial distribution remain poorly understood. Here, we analyze trajectory inference, deconvolute spatial transcriptomics at single-cell level and perform functional assays to generate a high-resolution integrated map of breast cancer (BC), with a focus on inflammatory and myofibroblastic (iCAF/myCAF) FAP+ CAF clusters. We identify 10 spatially-organized FAP+ CAF-related cellular niches, called EcoCellTypes, which are differentially localized within tumors. Consistent with their spatial organization, cancer cells drive the transition of detoxification-associated iCAF (Detox-iCAF) towards…
Citation impact
- FWCI
- 27.03
- Percentile
- 100%
- References
- 107
Authors
16- HCHugo CroizerCorresponding
Inserm, Université Paris Sciences et Lettres, La Ligue Contre le Cancer, Institut Curie
- RMRana Mhaidly
Inserm, Université Paris Sciences et Lettres, La Ligue Contre le Cancer, Institut Curie
- YKYann Kieffer
Inserm, Université Paris Sciences et Lettres, La Ligue Contre le Cancer, Institut Curie
- GGGéraldine Gentric
Inserm, Université Paris Sciences et Lettres, La Ligue Contre le Cancer, Institut Curie
- LDLounes Djerroudi
Inserm, Université Paris Sciences et Lettres, La Ligue Contre le Cancer, Institut Curie
Topics & keywords
- Breast cancer
- Extracellular matrix
- Ductal carcinoma
- Cancer research
- Tumour heterogeneity
- Phenotype
- Transcriptome
- Cancer cell
- Good health and well-being
Funding
- FSFondation Simone et Cino Del Duca
- EEquipexAwards: ANR-10-INBS-09-08, ANR-10-EQPX-03, INCa-DGOS-4654
- ANAgence Nationale de la RechercheAwards: 10-INBS-09-08, ANR-10-EQPX-03, ANR-10-INBS-09-08, ANR-10-INBS-09, 10-EQPX-03, ANR-21-RHUS-0002, ANR-10, 10-INBS-09, ANR-10-EQPX
- INInstitut National de la Santé et de la Recherche MédicaleAward: PC201317
- FPFondation pour la Recherche Médicale
- INInstitut National Du CancerAwards: CaLYS INCa-11692, INCa-11692, INCa-DGOS-9963, INCa-16101
- DGDirection Générale de l’offre de Soins